​

DURECT (DRRX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

DRRX Stock Rating

DURECT stock's rating consensus is Buy, based on 13 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 8 Buy (61.54%), 5 Hold (38.46%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 13 0 5 8 Strong Sell Sell Hold Buy Strong Buy

DRRX Price Target Upside V Benchmarks

TypeNameUpside
StockDURECT-
SectorHealthcare Stocks 24.81%
IndustrySpecialty & Generic Drug Manufacturers Stocks29.65%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$0.60$0.60$0.60
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 25-1---1
May, 25-21--3
Apr, 25-21--3
Mar, 25-21--3
Feb, 25-21--3
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jan 29, 2025H.C. WainwrightNeutralNeutralhold
May 22, 2024H.C. WainwrightNeutralNeutralhold

Financial Forecast

EPS Forecast

$-2 $-1 $0 $1 $2 $3 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.13$-1.69$-1.56$-1.22$-0.27----
Avg Forecast$-0.70$-1.77$-1.09$-1.38$-0.50$-0.52$-0.28$0.60$2.75
High Forecast$-0.67$-1.69$-0.66$-1.31$-0.18$-0.44$-0.28$0.60$2.75
Low Forecast$-0.73$-1.85$-1.84$-1.45$-0.68$-0.60$-0.28$0.60$2.75
Surprise %-81.43%-4.52%43.12%-11.59%-46.00%----

Revenue Forecast

$0 $30M $60M $90M $120M $150M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$30.11M$13.98M$19.28M$8.55M$2.03M----
Avg Forecast$34.70M$8.79M$19.47M$8.45M$12.93M$3.55M$20.76M$58.86M$144.62M
High Forecast$35.90M$9.09M$29.69M$9.81M$23.44M$3.55M$20.76M$58.86M$144.62M
Low Forecast$33.58M$8.50M$13.57M$7.76M$6.87M$3.55M$20.76M$58.86M$144.62M
Surprise %-13.23%59.07%-0.94%1.15%-84.30%----

Net Income Forecast

$-50M $-20M $10M $40M $70M $100M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.52M$-38.13M$-35.58M$-27.62M$-8.32M----
Avg Forecast$-18.56M$-46.85M$-41.39M$-27.62M$-17.07M$-13.79M$-7.43M$15.91M$72.93M
High Forecast$-17.79M$-44.89M$-33.11M$-22.10M$-4.74M$-11.67M$-7.43M$15.91M$72.93M
Low Forecast$-19.40M$-48.96M$-49.67M$-33.15M$-17.91M$-15.91M$-7.43M$15.91M$72.93M
Surprise %-86.41%-18.63%-14.03%--51.23%----

DRRX Forecast FAQ

Is DURECT stock a buy?

DURECT stock has a consensus rating of Buy, based on 13 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 8 Buy, 5 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that DURECT is a favorable investment for most analysts.

What is DURECT's price target?

DURECT's price target, set by 13 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $0.6.

How does DURECT stock forecast compare to its benchmarks?

DURECT's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (24.81%) and underperforming the specialty & generic drug manufacturers stocks industry (29.65%).

What is the breakdown of analyst ratings for DURECT over the past three months?

  • June 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 0% Strong Buy, 66.67% Buy, 33.33% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 0% Strong Buy, 66.67% Buy, 33.33% Hold, 0% Sell, 0% Strong Sell.

What is DURECT’s EPS forecast?

DURECT's average annual EPS forecast for its fiscal year ending in December 2025 is $-0.52, marking a 92.59% increase from the reported $-0.27 in 2024. Estimates for the following years are $-0.28 in 2026, $0.6 in 2027, and $2.75 in 2028.

What is DURECT’s revenue forecast?

DURECT's average annual revenue forecast for its fiscal year ending in December 2025 is $3.55M, reflecting a 74.79% increase from the reported $2.03M in 2024. The forecast for 2026 is $20.76M, followed by $58.86M for 2027, and $144.62M for 2028.

What is DURECT’s net income forecast?

DURECT's net income forecast for the fiscal year ending in December 2025 stands at $-13.79M, representing an 65.67% increase from the reported $-8.324M in 2024. Projections indicate $-7.426M in 2026, $15.91M in 2027, and $72.93M in 2028.